Member Info for alfista

I guess the market cap was much higher than that when you "gave the nod" to another holder to buy?

What do I foresee? Revenue growth, the speed and scale of which will determine the medium to long term prospects, or influence the sale of the entire company.

No one claimed anything about the sp.
The update specifically refers to potential business for Fruitflow.
If that potential is realised, the sp may respond, or may not.
Each to their own.
Seeking to re open the matter of confidential agreements established in industries that routinely operate in such a way is futile. IMHO

Was someone banned recently?

The confidentiality of the Alliance Agreemnt was news in 2010.
It isn't news now.
Fact.

That intimates that DSM are making a profit, another point that is impossible to prove either way.
Very clear that a multiple of current volume would make a big impact, and several multiples would make a huge impact.
The frustration that DSM have not yet delivered the big one extends right to the top of the company. However, the recent wording, that the potential is now multiples of current levels, suggests that there is knowledge of something larger on the horizon. Of course, there will be those who say that is lies, and no doubt they have invested accordingly. Each to their own, I assume everyone has a spread of investments, not just this one.

So you think DSM are telling lies when they say that they have to be fair to their partner companies because they rely heavily on the innovations brought to them by start up companies. If they stitch one up, who is going to bring the future products to them?

I know you love this point, because there is no way for anyone to provide proof, so you can take the cynical view as often as you like. Which you do.

Apart from the online sales, they don't market at all, simply isn't their role.

Either accept the view as expressed in the last update "potential many multiples of current level", or take the view of a 2 post wonder.
Each to their own.

Yes it does. Brokers have liability if they state something as fair.
Secrecy is the way the ingredient supply industry works, fact.

It was fair, independently judged

Any opinion is just that, details remain fully confidential.
The factors that we can see are the way DSM continue to give high visibility to Fruitflow, their enthusiasm doesn't appear to have diminished. In comparison By Health have only just started, but they have invested in trials and regulatory applications necessary to achieve top level approval in their market. Again, the level of commitment is undeniable.

We have never known the timescale involved, fact. But having two such major partners still fully behind Fruitflow should not be dismissed IMHO

On the one hand, you have the official RNS description of the agreement being independently adjudged as fair to both parties. Also you have DSM's mission statement about regarding inventions as vital to their own success, and stressing their responsibility to those companies that bring them innovations.

On the other hand, you have the posts on a chat board, where the poster found an opinion that no one could prove one way or the other due to the confidentiality of the document, therefore he keeps on repeating it.

Each to their own. Both parties made a huge financial commitment to establishing Fruitflow IP, and expanding it to global availability. That mutual commitment forms the basis of the Alliance Agreement.

So the decision made 9 years ago was a mistake in your view. In that case wise people like you have had ample time to adjust.

Barmy beyond belief.

Marketing o Fruitflow globally does not rest with the directors.
Fact.
The agreement does expire before much longer, is there an alternative to DSM ?
I think there may be.

Perhaps you could provide evidence to back up your defamation of the management. Of the roles defined in the Alliance Agreement, which tasks can you point to which have not been performed?

I'll talk to you again when I'm ready.
Not until.
Reason, I can't give it.

A balanced view from you Dior. Manipulation is an interesting concept, certainly the trades don't appear to be normal ones, since a fair few exceed the market size.
The product is good, I agree, and so are many of the brands who were early in the market. The decision to partner with DSM to exploit world markets appeared to be the only route back in 2010, Provexis simply didn't have the resources to go it alone. So responsibility for sales was handed to them, for whatever reason they haven't achieved the bigger brands , yet, that all of us hoped for. When the updates stated that future prospects could bring many multiples of current revenues, we assume they mean By Health, but it is quite feasible that DSM have other majors approaching a launch. The current share price is completely disconnected from those commercial matters, in fact there is a very low amount of the total shares in issue having been traded of late, and I think that very low volume may have contributed.
The reason for my silence is because I have to control my urge to respond to certain others, their vitriol really gets my goat.

My opinion is that the last update was vague on any timescales, which isn't helpful.

A vague possibility for some sells may be that folks have tax to pay. I just paid my Self Assessment, a painful moment. However, I must have received the income to incur the tax, so I can't complain. If others found themselves a bit stretched for readies, they may have needed to sell some shares. I don't know.
News fo the right sort would change to picture rapidly, I'm sure all of us would hope to see that soon.

Perhaps you could provide evidence to back up your defamation of the management. Of the roles defined in the Alliance Agreement, which tasks can you point to which have not been performed?

I really can't write what I want to in reply to your posts, but you know.

Total revenue for the year £236k (2017: £228k). Strong start to the 2018/19 financial year, with first quarter revenues ahead of first half revenues in 2017/18.

& Planned launch by BY-HEALTH of a number of Fruitflow based products in the Chinese market progressing well, with two studies successfully completed, one study currently ongoing at a clinical site and three further planned human studies confirmed by BY-HEALTH. The two completed studies (a human study and an animal study) showed excellent results in use for Fruitflow

It's an A trade for a pittance, this site stays with that price despite the Bid and Ask remaining unchanged.
Don't know why, but effectively there is no increase.

Agree. Medical advocacy is slow and expensive. Because we can't buy favour, the process is akin to knitting smoke.
By Health have the resources to provide the impetus, hopefully they will return from their new year celebrations with a commercial plan.

We live in hope.

A quick look at that charge states that Octet now have a first charge over assets, ranking them ahead of anyone else in the event it isn't repaid. Given that another financier had a charge that became a loan at 15% interest, better hope that this borrowing repays the first lot.

The dates against the two cases for that barrister are three years ago for GMM, and two years ago for WRN, when he obviously didn't succeed in challenging the liquidation order. How can anyone construe future value out of that?